Quercetin Inhibits Glioblastoma Growth and Prolongs Survival Rate through Inhibiting Glycolytic Metabolism

Abstract

Introduction: Quercetin has been reported to have anti-tumor activity of a wide range of cancers, including breast, lung, colon, prostate. Here, we investigated the protective role of quercetin in glioblastoma (GBM), which causes higher risk of morbidity and mortality, and explored the anti-tumor effects of quercetin on GBM using the U87MG and T98G cells and GBM mouse models. Methods: Cell viability and colony formation assays were performed by CCK-8 and clone formation assays. GBM xenograft mouse model was established to evaluate the tumor burden of mice treated with or without quercetin. To investigate spontaneous locomotor activity and survival rate of mice, orthotopic transplantation was performed through brain stereotaxic injection of U87 cells. Seahorse and Western blot were performed to examine the alteration of glycolytic metabolism GBM. Results: We found that quercetin administration inhibited GBM cell proliferation and promoted cell apoptosis in vitro. Quercetin suppressed GBM growth, restored spontaneous locomotor activity and improved survival rate without toxicity to peripheral organs in vivo. Moreover, quercetin inhibited glycolytic metabolism in tumor tissue. Discussion/Conclusion: Mechanistically, quercetin inhibited proliferation and angiogenesis, promoted cancer cell apoptosis, and finally improved locomotor activity and survival by inhibiting the glycolytic metabolism in GBM tissues, suggesting that quercetin is a potential drug for the treatment of GBM.

Network Pharmacology Analysis and Experimental Pharmacology Study Explore the Mechanism of Asparagus against Glioblastoma

“…Plant-derived quercetin is a favonoid with anticancer and antiproliferative properties [24]. According to multiple lines of evidence [25,26], a variety of proteins involved in GBM cell signaling are regulated by quercetin.…”

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling

“…One of the reasons for the failure of GBM therapy is that the BBB restricts the distribution of drugs in the brain. In recent years, many active ingredients of traditional Chinese medicine have made significant breakthroughs in the direction of anti-GBM, which achieved through various biological mechanisms to inhibit the occurrence of glioma ( Shi et al, 2022 ; Wang et al, 2022 ). We obtained irigenin by screening on the TCMSP database ( https://old.tcmsp-e.com/tcmsp.php ), from which BBB value showed that it could penetrate the blood-brain barrier ( Tattersall et al, 1975 ).…”

Quercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: An in vitro study

“…4 Previous studies have shown that this compound has antioxidant, 5 anti-inflammatory 6 and anti-cancer properties. 7 This antitumor activity can be exerted via several mechanisms such as alteration of tumour metabolism, 8 inhibition of angiogenesis, 9 improvement of tumours' chemosensitivity, 10 inhibition of the epithelial-tomesenchymal transition, 11 decreasing tumour invasion potential through downregulation of matrix metalloproteinases, 12 induction of apoptosis and inhibition of anti-apoptotic pathways. 13,14 Despite its efficacy and minimal side effects, the clinical application of quercetin is limited due to its low bioavailability.…”